Sara Raponi Selected Research

Sara Raponi Research Topics

9	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2011
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2014 - 12/2009
2	Disease Progression 12/2021 - 01/2021
1	Residual Neoplasm 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 06/2017
1	Infections 01/2017
1	Acute Promyelocytic Leukemia 11/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2011
1	Neoplasms (Cancer) 10/2011
1	Hematologic Diseases (Blood Diseases) 06/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2009

3	ibrutinibIBA 01/2022 - 10/2020
2	Rituximab (Mabthera)FDA Link 12/2021 - 10/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2017
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020
1	fludarabineIBA 11/2020
1	ofatumumab FDA Link 11/2020
1	Drug CombinationsIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 06/2017
1	OF 4680IBA 06/2017
1	CD34 Antigens (CD34 Antigen)IBA 11/2014
1	LigandsIBA 07/2014
1	Natural Killer Cell ReceptorsIBA 07/2014
1	Neutralizing AntibodiesIBA 07/2014
1	Immunoglobulin D (IgD)IBA 04/2013
1	AntibodiesIBA 10/2011
1	NucleophosminIBA 10/2011
1	Therapeutic UsesIBA 10/2011
1	Sialic Acid Binding Ig-like Lectin 3IBA 10/2011
1	AntigensIBA 10/2011
1	Monoclonal AntibodiesIBA 06/2011
1	CD19 AntigensIBA 06/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Tyrosine Kinase InhibitorsIBA 12/2009
1	bcr-abl Fusion ProteinsIBA 12/2009

2	Therapeutics 10/2011 - 06/2011
1	Immunotherapy 06/2011